Willie Lin
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Genetics 9
- Mesenchymal stem cell research 9
-
- Neonatal Respiratory Health Research 6
- Respiratory Support and Mechanisms 2
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
- Co-authors
- Subbaratnam Muthukrishnan (1 shared paper)Karabi Datta (1 shared paper)Swapan K. Datta (1 shared paper)Yu-Hsiang Huang (1 shared paper)C. S. Anuratha (1 shared paper)Ingo Potrykus (1 shared paper)Juite Wang (1 shared paper)Frederick O. Mueller (1 shared paper)
- Journals
- Stem Cell Research & Therapy (2 papers)Oncotarget (2 papers)Artificial Cells Nanomedicine and Biotechnology (1 paper)BioMetals (1 paper)PROTOPLASMA (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Willie Lin
27 papers receiving 766 citations
Peers
Comparison fields: 5 of 121
- Biotechnology 87
- Genetics 75
- Plant Science 248
- Orthopedics and Sports Medicine 46
- Management Science and Operations Research 63
Countries citing papers authored by Willie Lin
This map shows the geographic impact of Willie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willie Lin more than expected).
Fields of papers citing papers by Willie Lin
This network shows the impact of papers produced by Willie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willie Lin. The network helps show where Willie Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Willie Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 282 | |
| 2 | 2010 | 141 | |
| 3 | 2002 | 64 | |
| 4 | 2010 | 57 | |
| 5 | 1992 | 32 | |
| 6 | 2010 | 30 | |
| 7 | 2018 | 27 | |
| 8 | 2017 | 27 | |
| 9 | 2017 | 26 | |
| 10 | 2010 | 13 | |
| 11 | 1996 | 13 | |
| 12 | 2017 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2018 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2016 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2017 | 10 | |
| 19 | Allogeneic human umbilical cord-derived mesenchymal stem cells reduce lipopolysaccharide-induced inflammation and acute lung injury. | 2020 | 8 |
| 20 | 2021 | 7 |
About Willie Lin
Willie Lin is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Biotechnology, having authored 27 papers that have together received 827 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (9 papers), Neonatal Respiratory Health Research (6 papers), Transgenic Plants and Applications (3 papers), Respiratory Support and Mechanisms (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Congenital Diaphragmatic Hernia Studies (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Birth, Development, and Health (2 papers). The work is most often cited by research in Biotechnology (87 citations), Genetics (75 citations), Plant Science (248 citations), Orthopedics and Sports Medicine (46 citations) and Management Science and Operations Research (63 citations). Willie Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Subbaratnam Muthukrishnan, Karabi Datta, Swapan K. Datta, Yu-Hsiang Huang, C. S. Anuratha, Ingo Potrykus, Juite Wang, Frederick O. Mueller, Hsiu‐Chu Chou and Barry P. Boden. Their work appears in journals such as Stem Cell Research & Therapy, Oncotarget, Artificial Cells Nanomedicine and Biotechnology, BioMetals and PROTOPLASMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.